Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of a Tutored Theoretical-Practical Training to Develop Undergraduate Students' Skills for the Detection of Caries Lesions: Study Protocol for a Multicenter Controlled Randomized Study.
Braga MM, Lenzi TL, Ferreira FR, Mendes FM, Raggio DP, Imparato JC, Bonecker M, Magalhães AC, Wang L, Rios D, Pessan JP, Duque C, Rebelo MAB, Alves Filho AO, Lima MDM, Moura MS, De Carli AD, Sanabe ME, Cenci MS, Oliveira EF, Correa MB, Rocha RO, Zenkner JE, Murisí PU, Martignon S, Lara JS, Aquino FG, Carrillo A, Chu CH, Deery C, Ricketts D, Melo P, Antunes JLF, Ekstrand KR; IuSTC Group. Braga MM, et al. Among authors: rocha ro. JMIR Res Protoc. 2017 Aug 16;6(8):e155. doi: 10.2196/resprot.7414. JMIR Res Protoc. 2017. PMID: 28814381 Free PMC article.
Do adhesive systems influence the color match of resin composites?
Ritter DD, Rocha RO, Soares FZ, Lenzi TL. Ritter DD, et al. Among authors: rocha ro. J Appl Biomater Funct Mater. 2016 May 18;14(2):e212-6. doi: 10.5301/jabfm.5000277. J Appl Biomater Funct Mater. 2016. PMID: 27149943 Free article.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
68 results